{
    "nctId": "NCT06169007",
    "briefTitle": "Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer",
    "officialTitle": "Role of Soluble Immune Checkpoints Molecules as Diagnostic and Prognostic Markers in Breast Cancer Patients",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 84,
    "primaryOutcomeMeasure": "evaluate the levels of sTIM-3 and sCD40 in breast cancer patients in different stages and follow up their role in disease prognosis compared with healthy controls. Results will be compared with the previous studies.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients with breast cancer aged \\> 18 years attending the Medical Oncology department of South Egypt Cancer Institute\n\nExclusion Criteria:\n\n* Patients on chemotherapy\n* A history of any other malignancy\n* known (HIV) and/or hepatitis B or hepatitis C viruses,\n* pregnancy or breast feeding\n* patients or controls that refuse to be a part of the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}